Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Novavax (NASDAQ:NVAX) Shares Break Above 50 Day Moving Average - Here's What Happened
Novavax, Inc. (NASDAQ:NVAX) Stock Has Consensus Price Target of $12.33
Novavax Gains $125 Mln Payment As Sanofi Begins Phase 3 Combination Vaccine Trial; Stock Up
Novavax Earns $125 Million Milestone as Sanofi Launches Phase 3 Influenza-COVID-19 Combination Vaccine Trial in Europe
Novavax (NVAX) Expected to Post Earnings on Thursday
Novavax (NVAX) Stock May Be Above Fair Value On Current Sales
Financial Comparison: Novavax (NASDAQ:NVAX) and Beam Therapeutics (NASDAQ:BEAM) - Zolmax
Head-To-Head Contrast: Beam Therapeutics (NASDAQ:BEAM) & Novavax (NASDAQ:NVAX)
What Novavax Doubters Overlooked
Is Novavax (NVAX) Fully Priced Relative To Its Sales Base?
Novavax (NASDAQ:NVAX) Stock Falls 12.9% - Time to Sell?
3 Reasons NVAX is Risky and 1 Stock to Buy Instead
Novavax Plunges 12% as Selloff Hits Vaccine Makers; Moderna Tumbles 10%, Pfizer Holds Steady
Novavax (NASDAQ:NVAX) Shares Down 9.1% - Should You Sell?
Taiwan CDC to procure nearly 500,000 more flu, COVID-19 vaccine doses - Focus Taiwan
Head-To-Head Review: Novavax (NASDAQ:NVAX) & Alnylam Pharmaceuticals (NASDAQ:ALNY)
Novavax Soars 16%, Moderna Surges 11%, Merck Climbs 3% as Biotech Rallies
Novavax, Inc. $NVAX Position Lowered by Shah Capital Management - Zolmax
Novavax, Inc. $NVAX Stock Holdings Lessened by Shah Capital Management - Markets Daily
Novavax (NASDAQ:NVAX) Sees Strong Trading Volume - Should You Buy?
Novavax (NASDAQ:NVAX) Sees Large Volume Increase - Should You Buy? - Daily Political
Novavax (NVAX) Stock Could Be Above Fair Value As Plague Fears Fade
Novavax (NASDAQ:NVAX) Sets New 12-Month High - Here's What Happened - Markets Daily
Novavax Pulls Back From Plague-Scare Spike as Officials Call Risk Low; Moderna Nudges Higher, Pfizer Inches Higher
Novavax (NASDAQ:NVAX) Reaches New 1-Year High - Time to Buy?
NVAX, EBS, ARCT, MRNA Rally After Russia Plague Lab Worker's Death: Retail Traders Eye 'Contract Awards'
NVAX Stock Outruns Moderna As Vaxcyte's Shot Clears A Late-Stage Test
Investors Purchase Large Volume of Novavax Call Options (NASDAQ:NVAX)
Novavax Soars 22% as Sanofi Carries Nuvaxovid Into Vaccination Season; Moderna Climbs 8%, BioNTech Ticks Up
Novavax (NASDAQ:NVAX) Shares Up 10.5% - Here's Why
Novavax (NASDAQ:NVAX) Stock Jumps 10.5% - Still a Buy? - Daily Political
Novavax, Inc. (NASDAQ:NVAX) Stock Has Average Price Target of $14.00 According to Brokerages
Novavax (NASDAQ:NVAX) Stock Crosses Above 200 Day Moving Average - What's Next?
Novavax News
Boeing Stock Forecast 2026–2030: Can a Record $745 Billion Backlog Reverse BA’s 11% Earnings Sell-Off?
CoreWeave Stock Forecast 2026–2030: Can CRWV Recover From the AI Debt Sell-Off?
Nebius Stock Price Prediction 2026–2030: Can AI Cloud Growth Justify the Cost?
Eli Lilly Stock Forecast 2026–2030: Can LLY Break Above $1,300 After Its 7% Five-Session Rally?
Latest news
Show more
Amazon Q3 Earnings: AWS Growth Hits 39.3% as AI Spending Weighs on Cash Flow
Intel Stock Crashes 18% as Weak Q4 Forecast Overshadows 78% AI Server Growth
Bitcoin Price Falls Below $80,000 as Binance Reports $6.3 Billion Security Incident
Alphabet Stock Falls 12% as Search Slowdown and AI Spending Unsettle Investors
Apple Earnings Preview: Can iPhone Growth and the Duo Foldable Justify AAPL’s Valuation?
